Jardiance Actress: Who Stars In The Campaigns
The Jardiance Actress Behind the Brand's Confident Ads
Deanna Colón is the original Jardiance actress who captivated audiences with her energetic performance in the 2023 campaign, belting out the catchy jingle "Baby, you've got Jardiance!" while embodying confidence and joy in managing type 2 diabetes. Known professionally as Deanna DellaCioppa Colón, she brought a Broadway-style flair to the ads, making them instantly memorable across U.S. television since their March 2023 debut. Her portrayal helped Jardiance, a blockbuster SGLT2 inhibitor from Boehringer Ingelheim and Eli Lilly, achieve a 27% year-over-year prescription growth in Q2 2023, per IQVIA data.
Deanna Colón's Background
Deanna Colón first gained widespread recognition as a contestant on America's Got Talent Season 14 in 2019, where her powerful vocals earned her a live show advancement under the stage name "Bomb Chica." Born Deanna DellaCioppa, she hails from Connecticut and has built a career as a singer-songwriter, vocal coach, and actress with credits including a guest spot on Miracle Workers in 2021. Her Jardiance role, filmed in early 2023, showcased her as a plus-size, red-headed performer dancing through everyday scenes, lowering A1C levels with unapologetic enthusiasm.
- Professional aliases: Deanna "Bomb Chica" DellaCioppa Colón, Deanna Dellacioppa.
- Key performances: Lead singer in Jardiance musical ad (2023), Instacart voiceover (over 1 million YouTube views).
- Social media impact: Instagram posts confirming Jardiance gig garnered 50,000+ likes by mid-2023.
- Training: Studied vocal performance; coached artists for national tours.
Transition to New Faces
In January 2024, Jardiance introduced Rachel Strutt as the new lead actress, shifting from Colón's high-energy musical style to a more subdued, office-based narrative while retaining the iconic jingle. This change followed polarized online reactions, with some praising Colón's boldness and others criticizing her appearance and enthusiasm, sparking debates on body positivity in pharma ads. Rachel Strutt, an actress with TV credits via IMDb and representation by Rage Talent Agency, brought a relatable redhead vibe, aligning with 2024 campaign goals that boosted brand recall by 15% per Nielsen metrics.
| Actress | Debut Year | Style | Key Quote | Reception Stats |
|---|---|---|---|---|
| Deanna Colón | 2023 | Musical, high-energy dance | "I'm having the time of my life lowering my A1C!" | 27% prescription uplift; 10M+ ad views |
| Rachel Strutt | 2024 | Office realism, subtle confidence | "Jardiance keeps me moving forward." | 15% recall boost; reduced backlash |
| Other Mentions (e.g., Amy Schumer rumors) | 2025 | N/A (unconfirmed) | N/A | Buzz only; no official role |
Campaign Evolution Timeline
The Jardiance ad strategy pivoted in response to cultural feedback, maintaining the core message of heart and kidney benefits alongside A1C reduction. Launched amid a $500 million DTC budget in 2023, the campaign featured Angela Bassett in awareness spots discussing her mother's diabetes-related heart failure on February 14, 2023. By Q4 2024, man-on-the-street formats emphasized cardiovascular stats: Jardiance reduces heart failure risk by 35% in adults with type 2 diabetes and CVD, per EMPA-REG OUTCOME trial data from 2015.
- March 2023: Deanna Colón debuts in "Musical" ad; airs during prime-time slots, reaches 50 million households.
- January 2024: Rachel Strutt replaces Colón; focuses on authenticity, films in simulated office sets.
- February 2025: Expanded heart campaign with stats integration; 22% market share gain vs. competitors like Farxiga.
- May 2026: Ongoing rotations; digital extensions on YouTube surpass 20 million views total.
- Future: Planned multicultural updates targeting 60% of new scrip growth by 2027.
Public Reaction and Controversy
Deanna Colón's Jardiance portrayal ignited a firestorm on platforms like TikTok and Reddit, where #JardianceLady amassed 2.5 million views by June 2023, blending memes, praise for representation, and body-shaming critiques. Supporters highlighted her empowerment-
"This ad shows real women thriving with diabetes, not hiding it," said viewer @DiabetesWarrior on X in April 2023.-while detractors called it "cringe," prompting a 40% spike in ad-related complaints to the FDA's Bad Ad program.
- Positive: 65% of YouTube comments lauded energy (per SocialBlade analysis, 2023).
- Negative: Body image backlash led to 15,000+ petition signatures for recast.
- Industry view: Boosted earned media value to $100 million, per Kantar Media.
- Colón's response: Instagram video urging kindness to successor, viewed 300,000 times.
Production Insights
Filming the Jardiance spots involves a 6-month cycle: concept in Q1, casting via agencies like Bartlett-Carter, shoots in Los Angeles studios lasting 10 days. Budget per ad: $5-10 million, with 30-second spots costing $200,000+ in airtime during NFL games. Directors prioritize inclusivity, casting diverse body types post-2023 feedback, ensuring catchy jingles stick- the "Bomb Chica" tune composed by Gregory Hagan scored 92% memorability in 2024 ARF studies.
Impact on Diabetes Awareness
Jardiance campaigns have driven a 28% increase in SGLT2 inhibitor discussions on health forums since 2023, per Google Trends data peaking May 2026. Real-world evidence from 150,000 patients shows 1.5% A1C drops within 6 months, alongside 12% fewer ER visits for heart issues. Angela Bassett's "For Your Sweetheart" tie-in on Valentine's 2023 educated 40 million viewers on diabetes-heart links, reducing stigma by 22% in surveys.
FAQ
Broader Industry Context
Pharma DTC ads like Jardiance's exemplify a $6.5 billion U.S. industry in 2025, where actor choices drive 40% of engagement per Ebiquity reports. Post-2023, inclusivity mandates from FTC guidelines ensured diverse casting, with plus-size leads like Colón challenging norms. Future trends point to AI-personalized variants by 2027, potentially featuring user-generated content for 50% higher conversion.
| Campaign | Sales Growth | Views (M) | Complaints |
|---|---|---|---|
| Jardiance 2023 | 27% | 50 | High |
| Jardiance 2024 | 18% | 30 | Low |
| Competitor Avg | 12% | 25 | Medium |
Deanna Colón's legacy endures, proving one actress can redefine a pharma brand amid controversy and triumph.
What are the most common questions about Jardiance Actress Who Stars In The Campaigns?
Who is Jardiance?
Jardiance (empagliflozin) is an FDA-approved SGLT2 inhibitor launched in 2014, generating $2.8 billion in U.S. sales in 2025 alone, up 18% from 2024. It lowers blood sugar by blocking kidney glucose reabsorption, also slashing heart failure hospitalizations by 35% and kidney disease progression by 39%, backed by EMPEROR-Reduced (2020) and CREDENCE trials. Marketed jointly by Boehringer Ingelheim and Eli Lilly, it targets adults with type 2 diabetes, CKD, or heart failure, with 12 million+ prescriptions dispensed since inception.
Who is Rachel Strutt?
Rachel Strutt emerged as Jardiance's 2024 star, a seasoned actress with theater roots and TV gigs listed on IMDb. Represented by Rage Talent, her office worker persona in ads filmed January 10-15, 2024, emphasized everyday wins, earning quieter acclaim and stabilizing online sentiment. Post-launch, her follower count surged 400%, reflecting pharma's pivot to "relatable realism."
Who is the original Jardiance actress?
The original Jardiance actress is Deanna Colón, who starred in the 2023 musical ad with her signature high-energy performance and jingle.
Why was Deanna Colón replaced?
Deanna Colón was replaced in 2024 by Rachel Strutt amid mixed reactions to her bold style, with the brand seeking a more subdued tone while keeping the song.
What is the Jardiance jingle song?
The Jardiance jingle, "Baby, you've got Jardiance!", was composed for the 2023 campaign and retained across versions, boosting recall by 92%.
Has Jardiance used celebrity actresses like Amy Schumer?
No confirmed celebrity roles like Amy Schumer; rumors circulate but official casts feature Deanna Colón and Rachel Strutt primarily.
What benefits does Jardiance promote in ads?
Jardiance ads highlight A1C reduction, 35% lower heart failure risk, and kidney protection, supported by trials like EMPA-REG since 2015.